MYNZ
Income statement / Annual
Last year (2024), Mainz Biomed B.V.'s total revenue was $893.99 K,
a decrease of 0.17% from the previous year.
In 2024, Mainz Biomed B.V.'s net income was -$21.65 M.
See Mainz Biomed B.V.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$893.99 K |
$895.48 K |
$529.88 K |
$577.35 K |
$493.57 K |
$281.39 K |
| Cost of Revenue |
$319.11 K
|
$385.82 K
|
$347.73 K
|
$399.73 K
|
$370.48 K
|
$342.66 K
|
| Gross Profit |
$574.88 K
|
$509.66 K
|
$182.15 K
|
$177.62 K
|
$123.09 K
|
-$61.27 K
|
| Gross Profit Ratio |
0.64
|
0.57
|
0.34
|
0.31
|
0.25
|
-0.22
|
| Research and Development Expenses |
$5.84 M
|
$9.59 M
|
$3.66 M
|
$466.69 K
|
$311.85 K
|
$250.32 K
|
| General & Administrative Expenses |
$8.08 M
|
$13.42 M
|
$17.83 M
|
$8.45 M
|
$347.99 K
|
$388.79 K
|
| Selling & Marketing Expenses |
$4.70 M
|
$3.80 M
|
$4.98 M
|
$957.52 K
|
$110.38 K
|
$181.46 K
|
| Selling, General & Administrative Expenses |
$12.77 M
|
$17.22 M
|
$22.81 M
|
$9.41 M
|
$458.37 K
|
$570.25 K
|
| Other Expenses |
$656.34 K
|
$342.40 K
|
-$114.05 K
|
-$320.89 K
|
$26.58 K
|
-$130.35 K
|
| Operating Expenses |
$19.27 M
|
$27.15 M
|
$26.36 M
|
$9.56 M
|
$796.80 K
|
$690.21 K
|
| Cost And Expenses |
$19.59 M
|
$27.54 M
|
$26.97 M
|
$10.30 M
|
$1.17 M
|
$1.03 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$1.08 M
|
$809.58 K
|
$289.32 K
|
$339.17 K
|
$268.79 K
|
$201.94 K
|
| Depreciation & Amortization |
$1.02 M
|
$1.03 M
|
$459.43 K
|
$69.93 K
|
$152.84 K
|
$53.04 K
|
| EBITDA |
-$19.56 M |
-$25.01 M |
-$25.72 M |
-$11.28 M |
-$257.64 K |
-$702.08 K |
| EBITDA Ratio |
-21.88
|
-27.93
|
-48.54
|
-19.54
|
-0.52
|
-2.5
|
| Operating Income Ratio |
-20.91
|
-29.75
|
-49.91
|
-16.84
|
-1.55
|
-3.28
|
| Total Other Income/Expenses Net |
-$2.96 M
|
$348.96 K
|
$56.70 K
|
-$1.97 M
|
$86.82 K
|
-$35.15 K
|
| Income Before Tax |
-$21.65 M
|
-$26.30 M
|
-$26.39 M
|
-$11.70 M
|
-$586.90 K
|
-$957.06 K
|
| Income Before Tax Ratio |
-24.22
|
-29.36
|
-49.8
|
-20.26
|
-1.19
|
-3.4
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$377.12 K
|
$0.00
|
$0.00
|
| Net Income |
-$21.65 M
|
-$26.30 M
|
-$26.45 M
|
-$11.69 M
|
-$586.90 K
|
-$957.06 K
|
| Net Income Ratio |
-24.22
|
-29.36
|
-49.92
|
-20.25
|
-1.19
|
-3.4
|
| EPS |
-22.36 |
-1.62 |
-1.87 |
-1.67 |
-0.0501 |
-0.1 |
| EPS Diluted |
-22.36 |
-1.62 |
-1.87 |
-1.67 |
-0.0501 |
-0.1 |
| Weighted Average Shares Out |
$968.23 K
|
$16.24 M
|
$14.16 M
|
$7.21 M
|
$5.61 M
|
$11.71 M
|
| Weighted Average Shares Out Diluted |
$968.23 K
|
$16.24 M
|
$14.16 M
|
$7.21 M
|
$5.61 M
|
$11.71 M
|
| Link |
|
|
|
|
|
|
